English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Naturally occurring phenolic compounds have been shown to sensitize prostatecancer cells to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-inducedapoptosis. TRAIL is a potent stimulator of apoptosis in cancer cells and an importantimmune effector molecule in the surveillance and elimination of developing tumours.However, many cancer cells are resistant to TRAIL-mediated death. In this study,we aimed to determine the mechanisms by which TRAIL resistance can be overcomein prostate cancer cells by 3,5-diprenyl-4-hydroxycinnamic acid (artepillin C).Artepillin C is a bioactive component of Brazilian green propolis that possessesantitumour and chemopreventive activities. TRAIL-resistant LNCaP prostate cancercells were treated with TRAIL and artepillin C. Cytotoxicity was measured by MTTand lactate dehydrogenase (LDH) assays. Apoptosis was detected using Annexin V-FITCstaining by flow cytometry and fluorescence microscopy. Death receptor (DR) (TRAIL-R1/DR4and TRAIL-R2/DR5) expression was analyzed using flow cytometry. Mitochondrialmembrane potential (∆ψm) was evaluated using DePsipher staining by fluorescencemicro-scopy. The inhibition of NF-κB (p65) activation was confirmed with the ELISA-basedTransAM NF-κB kit. Caspase-8 and caspase-3 activities were determined by colorimetricprotease assays. The results showed that artepillin C sensitized the TRAIL-resistantLNCaP cells by engaging the extrinsic (receptor-mediated) and intrinsic (mitochondrial)apoptotic pathways. Artepillin C increased the expression of TRAIL-R2 and decreasedthe activity of NF-κB. Co-treatment with TRAIL and artepillin C induced the significantactivation of caspase-8 and caspase-3, as well as the disruption of ∆ψm. Thesefindings show that prostate cancer cells can be sensitized to TRAIL-mediated immunopreventionby artepillin C and confirm the role of phenolic compounds in prostate cancerimmunochemoprevention.

Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis